Sonja Clairmont
About Sonja Clairmont
Sonja Clairmont is a Data Specifications Manager at Bristol-Myers Squibb in New Jersey, with over a decade of experience in clinical data management and research.
Current Role at Bristol-Myers Squibb
Sonja Clairmont is currently employed as a Data Specifications Manager at Bristol-Myers Squibb. She began her role there in February 2018 and operates out of New Jersey, United States. In this position, Sonja oversees the management of data specifications, ensuring the accuracy and integrity of data crucial for the company’s pharmaceutical research and development efforts.
Professional Experience at Covance
Sonja Clairmont's professional journey at Covance spans multiple roles. From 2016 to 2018, she worked as an EDC Validation Coordinator in Princeton, New Jersey. Prior to that, she held the position of Architect Design and Standards Curator I from 2015 to 2016. Furthermore, from 2014 to 2015, she served as a Senior Clinical Data Coordinator. These roles collectively enhanced her expertise in clinical data management and validation processes.
Past Role as Clinical Data Manager
Sonja Clairmont worked as a Clinical Data Manager at Integrated Medical Development from 2012 to 2013. In this capacity, she was responsible for managing clinical data, ensuring data quality, and overseeing data collection processes.
Research Scientist at University of Medicine & Dentistry of New Jersey
From 2009 to 2012, Sonja Clairmont was a Research Scientist at the University of Medicine & Dentistry of New Jersey. In this role, she contributed to significant research projects, gaining extensive experience in scientific research methodologies and data analysis.
Early Career in Research
Sonja Clairmont began her career in research as a Research Assistant at Rockefeller University from 2003 to 2004. She then worked as a Senior Research Assistant at Memorial Sloan Kettering Cancer Center from 2004 to 2006. These roles provided her with a strong foundation in scientific research and hands-on experience in performing critical cancer research.